Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
The incidence of MDR-TB in new and retreatment cases of HIV and pulmonary tuberculosis co-infection Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013
Changing prevalence of MDR TB and XDR TB in a tertiary care hospital in India Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013
Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Trend in TB control in Republic of Moldova: High MDRTB burden country Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014
Multidrug-resistant and extensively drug resistance tuberculosis has a strong public health and economical impact in the Republic of Moldova Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013
High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons Source: International Congress 2015 – Screening strategies in TB Year: 2015
Transmission pattern of MDR-TB in Singapore 2005-2015 Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
MDR TB treatment results of GFATM program implementation in Tomsk, Russia Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Out-patient MDR-TB care in Moldova Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
MDR-TB treatment outcomes in HIV positive patients Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014
Rifampicin-resistant tuberculosis (RR-TB) in eastern Europe Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
Risk factor and resistance pattern of MDR TB among suspected cases of Oromia Region Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015
Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Knowledge and attitude about tuberculosis disease in a health workers population Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013
Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Features of different M.tuberculosis strains that were isolated from MDR-TB patients in Kharkiv, Ukraine Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
Study of prevalence of drug resistance in tuberculosis (TB) patients attending a tertiary care hospital at Mumbai Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
Prevalence of latent tuberculosis infection among household contacts and community controls in South India Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013